Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryn Nelson

Showing results (31-40 of 186) with videos related to

Pageof 19
Sort By:
Cancer Cytopathology|April 15, 2016
Rise of the predators: Business is booming in the murky global market of suspect and sham publishers and journalsBryn Nelson
Cancer Cytopathology|October 10, 2019
Recent advances in oncofertility address a serious side effect of cancer therapy: Researchers are making strides toward safeguarding and restoring fertility amid increasing efforts to lessen long-term organ damage from cancer therapiesBryn Nelson
Cancer Cytopathology|August 30, 2018
The curious case of repurposed remedies: Researchers are finding surprising success in reusing old agents as new cancer therapiesBryn Nelson
Nature|July 11, 2008
Benefits bluesBryn Nelson
Cancer Cytopathology|June 16, 2018
Stronger medical links for umbilical cord blood: Former medical waste is gaining ground as a potent therapeutic and research toolBryn Nelson
Cancer Cytopathology|June 14, 2012
Marking off new territory in the search for anticancer compounds: epigenetic mechanisms add complexity and promise to cancer research effortsBryn Nelson
Cancer Cytopathology|August 16, 2013
A bloodless coup?: Already a force in forensic pathology, virtual autopsies may be edging toward the hospitalBryn Nelson
Cancer Cytopathology|August 16, 2011
Heeding the hard lessons of Chernobyl: Japan avoids the worst so far, but experts push for long-term monitoringBryn Nelson
Cancer Cytopathology|December 16, 2011
Taking sides over taking call: New limits for first-year medical residents meet resistance from pathologistsBryn Nelson
Cancer Cytopathology|January 7, 2020
How dermatology is failing melanoma patients with skin of color: Unanswered questions on risk and eye-opening disparities in outcomes are weighing heavily on melanoma patients with darker skin. In this article, part 1 of a 2-part series, we explore the deadly consequences of racism and inequality in cancer careBryn Nelson
Pageof 19

Showing results (31-40 of 186) with videos related to

Sort By:
Pageof 19
Cancer Cytopathology|April 15, 2016
Rise of the predators: Business is booming in the murky global market of suspect and sham publishers and journalsBryn Nelson
Cancer Cytopathology|October 10, 2019
Recent advances in oncofertility address a serious side effect of cancer therapy: Researchers are making strides toward safeguarding and restoring fertility amid increasing efforts to lessen long-term organ damage from cancer therapiesBryn Nelson
Cancer Cytopathology|August 30, 2018
The curious case of repurposed remedies: Researchers are finding surprising success in reusing old agents as new cancer therapiesBryn Nelson
Nature|July 11, 2008
Benefits bluesBryn Nelson
Cancer Cytopathology|June 16, 2018
Stronger medical links for umbilical cord blood: Former medical waste is gaining ground as a potent therapeutic and research toolBryn Nelson
Cancer Cytopathology|June 14, 2012
Marking off new territory in the search for anticancer compounds: epigenetic mechanisms add complexity and promise to cancer research effortsBryn Nelson
Cancer Cytopathology|August 16, 2013
A bloodless coup?: Already a force in forensic pathology, virtual autopsies may be edging toward the hospitalBryn Nelson
Cancer Cytopathology|August 16, 2011
Heeding the hard lessons of Chernobyl: Japan avoids the worst so far, but experts push for long-term monitoringBryn Nelson
Cancer Cytopathology|December 16, 2011
Taking sides over taking call: New limits for first-year medical residents meet resistance from pathologistsBryn Nelson
Cancer Cytopathology|January 7, 2020
How dermatology is failing melanoma patients with skin of color: Unanswered questions on risk and eye-opening disparities in outcomes are weighing heavily on melanoma patients with darker skin. In this article, part 1 of a 2-part series, we explore the deadly consequences of racism and inequality in cancer careBryn Nelson
Pageof 19